- Price: $8,680,000
- NOI: $486,080
- Cap Rate: 5.60%
- Remaining Term: 15 years
- Escalations: 2% Annually throughout Primary Term
- Year Built: 2017
- Lease Type: NN (Roof & Structure)
Fresenius Medical is the World’s largest integrated provider of products and services for individuals undergoing Dialysis because of chronic kidney failure. Investment Grade (S&P BBB-) 2,200+ locations Market Capitalization $38 billion NYSE: FMS Pros: Fresenius is a leading provider in the Dialysis & Renal Care Industry. Strong Investment Grade parent company standing behind the lease. The 2% annual increases can go a long way in helping this investment stay competitive in the event that Cap Rates start to rise over the Primary Term Lease. Illinois is a Certificate of Need State which adds a significant barrier to entry for new competition. Cons: This is a Double Net Lease (NN) which means that the owner is responsible of the roof & structure of the property. The good news is that since this is new construction there is a warranty covering both roof & structure during the primary term.